- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06092203
Quality of Life for Pediatric Urolithiasis (Elattar)
October 15, 2023 updated by: Ahmed R. EL-Nahas, Mansoura University
Assessment of Health-Related Quality of Life for Pediatric Patients With Urinary Stone Disease.
The aim of this study is to assess the quality of life (QoL) in pediatric patients with urinary stone disease.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study will assess the quality of life (QoL) in pediatric patients with urinary stone disease using the pediatric quality of life (PedsQol) questionnaire in comparison to normal healthy age/sex matched population.
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed R EL-Nahas, MD
- Phone Number: +201221136899
- Email: ar_el_nahas@yahoo.com
Study Locations
-
-
-
Mansoura, Egypt, 35516
- Recruiting
- Urology and nephrology center
-
Contact:
- M
-
Contact:
- Ahmed R EL-Nahas, MD
- Phone Number: 00201221136899
- Email: ar_el_nahas@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
All pediatric patients with urolithiasis.
Description
Inclusion Criteria:
- Patients who had urinary stones
Exclusion Criteria:
- Patients presenting with obstructive uropathy or urosepsis.
- Recent (less than 4 weeks) surgical intervention for urinary stone disease.
- Indwelling urinary catheters or stents (urethral catheter, ureteral stents or nephrostomy tube).
- Associated mental illness or cognitive dysfunction.
- Associated chronic medical illness that may compromise QoL.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients
Pediatric patients who underwent treatment for utrollithiasis.
|
|
Control
Cross-matched group of healthy children.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The PedsQL questionnaire
Time Frame: 12 months
|
comparison of overall PedsQL score between pediatric urolithiasis patients and normal healthy age/sex matched population.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed R EL-Nahas, MD, Mansoura University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
October 1, 2024
Study Registration Dates
First Submitted
October 10, 2023
First Submitted That Met QC Criteria
October 15, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Actual)
October 23, 2023
Last Update Submitted That Met QC Criteria
October 15, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2278
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric ALL
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Istanbul University - CerrahpasaNot yet recruitingPediatric Anesthesia | Pediatric Postoperative Recovery | Pediatric Enhanced Recovery After SurgeryTurkey (Türkiye)
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation in ChildrenCompletedPediatric Heart Transplantation | Pediatric Heart Transplant Recipients | Pediatric Cardiac TransplantationUnited States
-
Muhammed Ata Nur GEÇERBakirkoy Dr. Sadi Konuk Research and Training HospitalNot yet recruitingPediatric | Pediatric Acute Upper Respiratory Tract Infection | Pediatric Acute Respiratory Failure
-
Akdeniz UniversityNot yet recruitingPediatric Oncology | Pediatric Hematology
-
University Hospital, Strasbourg, FranceTerminatedPediatric Lung Ultrasound | Pediatric Chest Radiography | Pediatric Lung DiagnosisFrance
-
Duke UniversityRecruiting
-
TC Erciyes UniversityCompletedPediatric Cancer | Pediatric Brain Tumor | Pediatric Solid TumorTurkey
-
Alexandria UniversityNot yet recruitingPediatric Dental Anxiety | Pediatric Dental PainEgypt